Thorne HealthTech launched its IPO, registering with the SEC to offer 9 million shares. The IPO price is expected to be between $13 and $15 per share.
The underwriters will have an option to purchase up to an additional 1.35 million shares.
Thorne HealthTech has applied to list on the Nasdaq under THRN.
BofA Securities, Cowen and Evercore are lead book-running managers for the proposed offering. RBC Capital Markets is acting as an additional book-running manager. Read more.
